PILOT TRIAL OF DRONABINOL ADJUNCTIVE TREATMENT OF AGITATION IN ALZHEIMER'S DISEASE (THC-AD)

被引：0
|
作者：
Outen, John [1 ]
Rosenberg, Paul [1 ]
Vandrey, Ryan [1 ]
Amjad, Halima [1 ]
Burhanullah, Haroon [1 ]
Agronin, Marc [4 ]
Castaneda, Ricardo [4 ]
Isesalaya, Maria [4 ]
Walsh, Patricia [5 ]
Ash, Eleanor [2 ]
Cohen, Leah [2 ]
Wilkins, James [3 ]
Harper, David [3 ]
Forester, Brent [3 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] McLean Hosp, Belmont, MA USA
[3] Harvard Med Sch, McLean Hosp, Boston, MA 02115 USA
[4] Miami Jewish Hlth, Miami, FL USA
[5] North Shore Med Ctr, Salem, MA USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
NR-12
引用
收藏
页码：S115 / S117
页数：4
相关论文
共 50 条
  • [1] TRIAL OF DRONABINOL ADJUNCTIVE TREATMENT OF AGITATION IN ALZHEIMER'S DISEASE (AD) (THC-AD)
    Rosenberg, Paul
    Forester, Brent
    Agronin, Marc
    Kasckow, John
    Amjad, Halima
    Burhanullah, Haroon
    Vandrey, Ryan
    Outen, John
    Skurla, Miranda
    May, Rose
    Isesalaya, Maria
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : S121 - S122
  • [2] Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THC-AD)
    Cohen, Leah M.
    Ash, Eleanor
    Outen, John D.
    Vandrey, Ryan
    Amjad, Halima
    Agronin, Marc
    Burhanullah, M. Haroon
    Walsh, Patricia
    Wilkins, James M.
    Leoutsakos, Jeannie-Marie
    Nowrangi, Milap A.
    Harper, David
    Rosenberg, Paul B.
    Forester, Brent P.
    INTERNATIONAL PSYCHOGERIATRICS, 2021, : 1 - 6
  • [3] Safety and efficacy of dronabinol in the treatment of agitation in patients with Alzheimer's disease: A pilot study in community dwelling patients refractory to traditional medicine
    Shua-Haim, JR
    Pass, MD
    Patel, S
    Patel, S
    Lee, P
    NEUROBIOLOGY OF AGING, 2004, 25 : S331 - S331
  • [4] Safety and efficacy of dronabinol in the treatment of agitation in patients with Alzheimer's disease with anorexia: A retrospective chart review
    Patel, S
    Shua-Haim, JR
    Pass, M
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 313 - 313
  • [5] Safety & efficacy of dronabinol for the treatment of refractory depression in patients with Alzheimer's disease (AD): A pilot study in an assisted living facility
    Patel, S
    Pass, M
    Patel, P
    Shua-Haim, J
    Patel, S
    Lee, P
    GERONTOLOGIST, 2004, 44 : 472 - 472
  • [6] Brief Psychosocial Therapy for the Treatment of Agitation in Alzheimer Disease (The CALM-AD Trial)
    Ballard, Clive
    Brown, Richard
    Fossey, Jane
    Douglas, Simon
    Bradley, Paul
    Hancock, Judith
    James, Ian A.
    Juszczak, Edmund
    Bentham, Peter
    Burns, Alistair
    Lindesay, James
    Jacoby, Robin
    O'Brien, John
    Bullock, Roger
    Johnson, Tony
    Holmes, Clive
    Howard, Robert
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (09): : 726 - 733
  • [7] Disentangling the Treatment of Agitation in Alzheimer's Disease
    Howard, Robert J.
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (05): : 441 - 443
  • [8] Donepezil for the treatment of agitation in Alzheimer's disease
    Howard, Robert J.
    Juszczak, Edmund
    Ballard, Clive G.
    Bentham, Peter
    Brown, Richard G.
    Bullock, Roger
    Burns, Alistair S.
    Holmes, Clive
    Jacoby, Robin
    Johnson, Tony
    Knapp, Martin
    Lindesay, James
    O'Brien, John T.
    Wilcock, Gordon
    Katona, Cornelius
    Jones, Roy W.
    DeCesare, Julia
    Rodger, Michaela
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (14): : 1382 - 1392
  • [9] Advancements in the treatment of agitation in Alzheimer's disease
    Antonsdottir, Inga M.
    Smith, Jessica
    Keltz, Melanie
    Porsteinsson, Anton P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (11) : 1649 - 1656
  • [10] Prazosin for Disruptive Agitation in Alzheimer's Disease: PEACE-AD
    Peskind, Elaine
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 62 - 62
12345